- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.88 Å
- Oligo State
- homo-hexamer
- Ligands
- 12 x SO4: SULFATE ION(Non-functional Binders)
- 150 x CL: CHLORIDE ION(Non-functional Binders)
CL.3: 3 residues within 4Å:- Chain A: Y.305, K.308
- Chain D: Q.70
Ligand excluded by PLIPCL.4: 2 residues within 4Å:- Chain A: K.308
- Chain B: K.160
Ligand excluded by PLIPCL.5: 5 residues within 4Å:- Chain A: K.160, S.161, S.164
- Chain E: K.75
- Ligands: CL.63
Ligand excluded by PLIPCL.6: 5 residues within 4Å:- Chain A: I.256, H.257, I.258, S.290
- Ligands: CL.26
Ligand excluded by PLIPCL.7: 3 residues within 4Å:- Chain A: E.172, E.175
- Chain E: K.35
Ligand excluded by PLIPCL.8: 4 residues within 4Å:- Chain A: D.151, F.208, K.264, K.277
Ligand excluded by PLIPCL.9: 5 residues within 4Å:- Chain A: E.307, D.313
- Chain B: S.161
- Chain D: K.75
- Ligands: CL.32
Ligand excluded by PLIPCL.10: 5 residues within 4Å:- Chain A: P.133, I.181, K.182, F.183
- Ligands: CL.25
Ligand excluded by PLIPCL.11: 3 residues within 4Å:- Chain D: A.118, A.119
- Ligands: CL.92
Ligand excluded by PLIPCL.12: 2 residues within 4Å:- Chain A: E.274, K.277
Ligand excluded by PLIPCL.13: 4 residues within 4Å:- Chain A: E.142
- Chain D: D.268, D.337, D.338
Ligand excluded by PLIPCL.14: 3 residues within 4Å:- Chain A: E.271, E.274, I.275
Ligand excluded by PLIPCL.15: 6 residues within 4Å:- Chain A: K.160, S.161, F.187
- Chain C: D.313, R.316
- Ligands: CL.16
Ligand excluded by PLIPCL.16: 4 residues within 4Å:- Chain A: S.161, E.162, F.187
- Ligands: CL.15
Ligand excluded by PLIPCL.17: 3 residues within 4Å:- Chain A: I.136, S.138
- Chain D: D.338
Ligand excluded by PLIPCL.18: 6 residues within 4Å:- Chain A: L.34, Y.37, D.38, L.105, K.106, G.107
Ligand excluded by PLIPCL.19: 2 residues within 4Å:- Chain A: K.198, M.199
Ligand excluded by PLIPCL.20: 2 residues within 4Å:- Chain A: E.135, I.136
Ligand excluded by PLIPCL.21: 4 residues within 4Å:- Chain A: K.168, A.169, E.172
- Chain E: K.36
Ligand excluded by PLIPCL.22: 3 residues within 4Å:- Chain A: K.160, N.200
- Chain C: K.311
Ligand excluded by PLIPCL.23: 1 residues within 4Å:- Chain A: Y.166
Ligand excluded by PLIPCL.24: 4 residues within 4Å:- Chain A: D.38
- Chain E: E.162, Y.167, K.168
Ligand excluded by PLIPCL.25: 4 residues within 4Å:- Chain A: E.135, K.182, F.183
- Ligands: CL.10
Ligand excluded by PLIPCL.26: 4 residues within 4Å:- Chain A: D.288, L.289, S.290
- Ligands: CL.6
Ligand excluded by PLIPCL.27: 3 residues within 4Å:- Chain A: D.108, R.109, E.175
Ligand excluded by PLIPCL.30: 3 residues within 4Å:- Chain B: Y.305, K.308
- Chain F: Q.70
Ligand excluded by PLIPCL.31: 1 residues within 4Å:- Chain B: K.308
Ligand excluded by PLIPCL.32: 5 residues within 4Å:- Chain B: K.160, S.161, S.164
- Chain D: K.75
- Ligands: CL.9
Ligand excluded by PLIPCL.33: 5 residues within 4Å:- Chain B: I.256, H.257, I.258, S.290
- Ligands: CL.53
Ligand excluded by PLIPCL.34: 3 residues within 4Å:- Chain B: E.172, E.175
- Chain D: K.35
Ligand excluded by PLIPCL.35: 4 residues within 4Å:- Chain B: D.151, F.208, K.264, K.277
Ligand excluded by PLIPCL.36: 3 residues within 4Å:- Chain B: E.307, D.313
- Chain F: K.75
Ligand excluded by PLIPCL.37: 5 residues within 4Å:- Chain B: P.133, I.181, K.182, F.183
- Ligands: CL.52
Ligand excluded by PLIPCL.38: 3 residues within 4Å:- Chain F: A.118, A.119
- Ligands: CL.146
Ligand excluded by PLIPCL.39: 2 residues within 4Å:- Chain B: E.274, K.277
Ligand excluded by PLIPCL.40: 4 residues within 4Å:- Chain B: E.142
- Chain F: D.268, D.337, D.338
Ligand excluded by PLIPCL.41: 3 residues within 4Å:- Chain B: E.271, E.274, I.275
Ligand excluded by PLIPCL.42: 6 residues within 4Å:- Chain A: D.313, R.316
- Chain B: K.160, S.161, F.187
- Ligands: CL.43
Ligand excluded by PLIPCL.43: 4 residues within 4Å:- Chain B: S.161, E.162, F.187
- Ligands: CL.42
Ligand excluded by PLIPCL.44: 3 residues within 4Å:- Chain B: I.136, S.138
- Chain F: D.338
Ligand excluded by PLIPCL.45: 6 residues within 4Å:- Chain B: L.34, Y.37, D.38, L.105, K.106, G.107
Ligand excluded by PLIPCL.46: 2 residues within 4Å:- Chain B: K.198, M.199
Ligand excluded by PLIPCL.47: 2 residues within 4Å:- Chain B: E.135, I.136
Ligand excluded by PLIPCL.48: 4 residues within 4Å:- Chain B: K.168, A.169, E.172
- Chain D: K.36
Ligand excluded by PLIPCL.49: 3 residues within 4Å:- Chain A: K.311
- Chain B: K.160, N.200
Ligand excluded by PLIPCL.50: 1 residues within 4Å:- Chain B: Y.166
Ligand excluded by PLIPCL.51: 4 residues within 4Å:- Chain B: D.38
- Chain D: E.162, Y.167, K.168
Ligand excluded by PLIPCL.52: 4 residues within 4Å:- Chain B: E.135, K.182, F.183
- Ligands: CL.37
Ligand excluded by PLIPCL.53: 4 residues within 4Å:- Chain B: D.288, L.289, S.290
- Ligands: CL.33
Ligand excluded by PLIPCL.54: 3 residues within 4Å:- Chain B: D.108, R.109, E.175
Ligand excluded by PLIPCL.57: 3 residues within 4Å:- Chain C: Y.305, K.308
- Chain E: Q.70
Ligand excluded by PLIPCL.58: 2 residues within 4Å:- Chain A: K.160
- Chain C: K.308
Ligand excluded by PLIPCL.59: 3 residues within 4Å:- Chain C: K.160, S.161, S.164
Ligand excluded by PLIPCL.60: 5 residues within 4Å:- Chain C: I.256, H.257, I.258, S.290
- Ligands: CL.80
Ligand excluded by PLIPCL.61: 2 residues within 4Å:- Chain C: E.172, E.175
Ligand excluded by PLIPCL.62: 4 residues within 4Å:- Chain C: D.151, F.208, K.264, K.277
Ligand excluded by PLIPCL.63: 5 residues within 4Å:- Chain A: S.161
- Chain C: E.307, D.313
- Chain E: K.75
- Ligands: CL.5
Ligand excluded by PLIPCL.64: 5 residues within 4Å:- Chain C: P.133, I.181, K.182, F.183
- Ligands: CL.79
Ligand excluded by PLIPCL.65: 3 residues within 4Å:- Chain E: A.118, A.119
- Ligands: CL.119
Ligand excluded by PLIPCL.66: 2 residues within 4Å:- Chain C: E.274, K.277
Ligand excluded by PLIPCL.67: 4 residues within 4Å:- Chain C: E.142
- Chain E: D.268, D.337, D.338
Ligand excluded by PLIPCL.68: 3 residues within 4Å:- Chain C: E.271, E.274, I.275
Ligand excluded by PLIPCL.69: 4 residues within 4Å:- Chain C: K.160, S.161, F.187
- Ligands: CL.70
Ligand excluded by PLIPCL.70: 4 residues within 4Å:- Chain C: S.161, E.162, F.187
- Ligands: CL.69
Ligand excluded by PLIPCL.71: 3 residues within 4Å:- Chain C: I.136, S.138
- Chain E: D.338
Ligand excluded by PLIPCL.72: 6 residues within 4Å:- Chain C: L.34, Y.37, D.38, L.105, K.106, G.107
Ligand excluded by PLIPCL.73: 2 residues within 4Å:- Chain C: K.198, M.199
Ligand excluded by PLIPCL.74: 2 residues within 4Å:- Chain C: E.135, I.136
Ligand excluded by PLIPCL.75: 3 residues within 4Å:- Chain C: K.168, A.169, E.172
Ligand excluded by PLIPCL.76: 2 residues within 4Å:- Chain C: K.160, N.200
Ligand excluded by PLIPCL.77: 1 residues within 4Å:- Chain C: Y.166
Ligand excluded by PLIPCL.78: 1 residues within 4Å:- Chain C: D.38
Ligand excluded by PLIPCL.79: 4 residues within 4Å:- Chain C: E.135, K.182, F.183
- Ligands: CL.64
Ligand excluded by PLIPCL.80: 4 residues within 4Å:- Chain C: D.288, L.289, S.290
- Ligands: CL.60
Ligand excluded by PLIPCL.81: 3 residues within 4Å:- Chain C: D.108, R.109, E.175
Ligand excluded by PLIPCL.84: 3 residues within 4Å:- Chain A: Q.70
- Chain D: Y.305, K.308
Ligand excluded by PLIPCL.85: 2 residues within 4Å:- Chain D: K.308
- Chain E: K.160
Ligand excluded by PLIPCL.86: 5 residues within 4Å:- Chain B: K.75
- Chain D: K.160, S.161, S.164
- Ligands: CL.144
Ligand excluded by PLIPCL.87: 5 residues within 4Å:- Chain D: I.256, H.257, I.258, S.290
- Ligands: CL.107
Ligand excluded by PLIPCL.88: 3 residues within 4Å:- Chain B: K.35
- Chain D: E.172, E.175
Ligand excluded by PLIPCL.89: 4 residues within 4Å:- Chain D: D.151, F.208, K.264, K.277
Ligand excluded by PLIPCL.90: 5 residues within 4Å:- Chain A: K.75
- Chain D: E.307, D.313
- Chain E: S.161
- Ligands: CL.113
Ligand excluded by PLIPCL.91: 5 residues within 4Å:- Chain D: P.133, I.181, K.182, F.183
- Ligands: CL.106
Ligand excluded by PLIPCL.92: 3 residues within 4Å:- Chain A: A.118, A.119
- Ligands: CL.11
Ligand excluded by PLIPCL.93: 2 residues within 4Å:- Chain D: E.274, K.277
Ligand excluded by PLIPCL.94: 4 residues within 4Å:- Chain A: D.268, D.337, D.338
- Chain D: E.142
Ligand excluded by PLIPCL.95: 3 residues within 4Å:- Chain D: E.271, E.274, I.275
Ligand excluded by PLIPCL.96: 6 residues within 4Å:- Chain D: K.160, S.161, F.187
- Chain F: D.313, R.316
- Ligands: CL.97
Ligand excluded by PLIPCL.97: 4 residues within 4Å:- Chain D: S.161, E.162, F.187
- Ligands: CL.96
Ligand excluded by PLIPCL.98: 3 residues within 4Å:- Chain A: D.338
- Chain D: I.136, S.138
Ligand excluded by PLIPCL.99: 6 residues within 4Å:- Chain D: L.34, Y.37, D.38, L.105, K.106, G.107
Ligand excluded by PLIPCL.100: 2 residues within 4Å:- Chain D: K.198, M.199
Ligand excluded by PLIPCL.101: 2 residues within 4Å:- Chain D: E.135, I.136
Ligand excluded by PLIPCL.102: 4 residues within 4Å:- Chain B: K.36
- Chain D: K.168, A.169, E.172
Ligand excluded by PLIPCL.103: 3 residues within 4Å:- Chain D: K.160, N.200
- Chain F: K.311
Ligand excluded by PLIPCL.104: 1 residues within 4Å:- Chain D: Y.166
Ligand excluded by PLIPCL.105: 4 residues within 4Å:- Chain B: E.162, Y.167, K.168
- Chain D: D.38
Ligand excluded by PLIPCL.106: 4 residues within 4Å:- Chain D: E.135, K.182, F.183
- Ligands: CL.91
Ligand excluded by PLIPCL.107: 4 residues within 4Å:- Chain D: D.288, L.289, S.290
- Ligands: CL.87
Ligand excluded by PLIPCL.108: 3 residues within 4Å:- Chain D: D.108, R.109, E.175
Ligand excluded by PLIPCL.111: 3 residues within 4Å:- Chain C: Q.70
- Chain E: Y.305, K.308
Ligand excluded by PLIPCL.112: 1 residues within 4Å:- Chain E: K.308
Ligand excluded by PLIPCL.113: 5 residues within 4Å:- Chain A: K.75
- Chain E: K.160, S.161, S.164
- Ligands: CL.90
Ligand excluded by PLIPCL.114: 5 residues within 4Å:- Chain E: I.256, H.257, I.258, S.290
- Ligands: CL.134
Ligand excluded by PLIPCL.115: 3 residues within 4Å:- Chain A: K.35
- Chain E: E.172, E.175
Ligand excluded by PLIPCL.116: 4 residues within 4Å:- Chain E: D.151, F.208, K.264, K.277
Ligand excluded by PLIPCL.117: 3 residues within 4Å:- Chain C: K.75
- Chain E: E.307, D.313
Ligand excluded by PLIPCL.118: 5 residues within 4Å:- Chain E: P.133, I.181, K.182, F.183
- Ligands: CL.133
Ligand excluded by PLIPCL.119: 3 residues within 4Å:- Chain C: A.118, A.119
- Ligands: CL.65
Ligand excluded by PLIPCL.120: 2 residues within 4Å:- Chain E: E.274, K.277
Ligand excluded by PLIPCL.121: 4 residues within 4Å:- Chain C: D.268, D.337, D.338
- Chain E: E.142
Ligand excluded by PLIPCL.122: 3 residues within 4Å:- Chain E: E.271, E.274, I.275
Ligand excluded by PLIPCL.123: 6 residues within 4Å:- Chain D: D.313, R.316
- Chain E: K.160, S.161, F.187
- Ligands: CL.124
Ligand excluded by PLIPCL.124: 4 residues within 4Å:- Chain E: S.161, E.162, F.187
- Ligands: CL.123
Ligand excluded by PLIPCL.125: 3 residues within 4Å:- Chain C: D.338
- Chain E: I.136, S.138
Ligand excluded by PLIPCL.126: 6 residues within 4Å:- Chain E: L.34, Y.37, D.38, L.105, K.106, G.107
Ligand excluded by PLIPCL.127: 2 residues within 4Å:- Chain E: K.198, M.199
Ligand excluded by PLIPCL.128: 2 residues within 4Å:- Chain E: E.135, I.136
Ligand excluded by PLIPCL.129: 4 residues within 4Å:- Chain A: K.36
- Chain E: K.168, A.169, E.172
Ligand excluded by PLIPCL.130: 3 residues within 4Å:- Chain D: K.311
- Chain E: K.160, N.200
Ligand excluded by PLIPCL.131: 1 residues within 4Å:- Chain E: Y.166
Ligand excluded by PLIPCL.132: 4 residues within 4Å:- Chain A: E.162, Y.167, K.168
- Chain E: D.38
Ligand excluded by PLIPCL.133: 4 residues within 4Å:- Chain E: E.135, K.182, F.183
- Ligands: CL.118
Ligand excluded by PLIPCL.134: 4 residues within 4Å:- Chain E: D.288, L.289, S.290
- Ligands: CL.114
Ligand excluded by PLIPCL.135: 3 residues within 4Å:- Chain E: D.108, R.109, E.175
Ligand excluded by PLIPCL.138: 3 residues within 4Å:- Chain B: Q.70
- Chain F: Y.305, K.308
Ligand excluded by PLIPCL.139: 2 residues within 4Å:- Chain D: K.160
- Chain F: K.308
Ligand excluded by PLIPCL.140: 3 residues within 4Å:- Chain F: K.160, S.161, S.164
Ligand excluded by PLIPCL.141: 5 residues within 4Å:- Chain F: I.256, H.257, I.258, S.290
- Ligands: CL.161
Ligand excluded by PLIPCL.142: 2 residues within 4Å:- Chain F: E.172, E.175
Ligand excluded by PLIPCL.143: 4 residues within 4Å:- Chain F: D.151, F.208, K.264, K.277
Ligand excluded by PLIPCL.144: 5 residues within 4Å:- Chain B: K.75
- Chain D: S.161
- Chain F: E.307, D.313
- Ligands: CL.86
Ligand excluded by PLIPCL.145: 5 residues within 4Å:- Chain F: P.133, I.181, K.182, F.183
- Ligands: CL.160
Ligand excluded by PLIPCL.146: 3 residues within 4Å:- Chain B: A.118, A.119
- Ligands: CL.38
Ligand excluded by PLIPCL.147: 2 residues within 4Å:- Chain F: E.274, K.277
Ligand excluded by PLIPCL.148: 4 residues within 4Å:- Chain B: D.268, D.337, D.338
- Chain F: E.142
Ligand excluded by PLIPCL.149: 3 residues within 4Å:- Chain F: E.271, E.274, I.275
Ligand excluded by PLIPCL.150: 4 residues within 4Å:- Chain F: K.160, S.161, F.187
- Ligands: CL.151
Ligand excluded by PLIPCL.151: 4 residues within 4Å:- Chain F: S.161, E.162, F.187
- Ligands: CL.150
Ligand excluded by PLIPCL.152: 3 residues within 4Å:- Chain B: D.338
- Chain F: I.136, S.138
Ligand excluded by PLIPCL.153: 6 residues within 4Å:- Chain F: L.34, Y.37, D.38, L.105, K.106, G.107
Ligand excluded by PLIPCL.154: 2 residues within 4Å:- Chain F: K.198, M.199
Ligand excluded by PLIPCL.155: 2 residues within 4Å:- Chain F: E.135, I.136
Ligand excluded by PLIPCL.156: 3 residues within 4Å:- Chain F: K.168, A.169, E.172
Ligand excluded by PLIPCL.157: 2 residues within 4Å:- Chain F: K.160, N.200
Ligand excluded by PLIPCL.158: 1 residues within 4Å:- Chain F: Y.166
Ligand excluded by PLIPCL.159: 1 residues within 4Å:- Chain F: D.38
Ligand excluded by PLIPCL.160: 4 residues within 4Å:- Chain F: E.135, K.182, F.183
- Ligands: CL.145
Ligand excluded by PLIPCL.161: 4 residues within 4Å:- Chain F: D.288, L.289, S.290
- Ligands: CL.141
Ligand excluded by PLIPCL.162: 3 residues within 4Å:- Chain F: D.108, R.109, E.175
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Titus, E.W. et al., The structure of a calsequestrin filament reveals mechanisms of familial arrhythmia. Nat.Struct.Mol.Biol. (2020)
- Release Date
- 2020-07-01
- Peptides
- Calsequestrin-2: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
AE
AF
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.88 Å
- Oligo State
- homo-hexamer
- Ligands
- 12 x SO4: SULFATE ION(Non-functional Binders)
- 150 x CL: CHLORIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Titus, E.W. et al., The structure of a calsequestrin filament reveals mechanisms of familial arrhythmia. Nat.Struct.Mol.Biol. (2020)
- Release Date
- 2020-07-01
- Peptides
- Calsequestrin-2: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
AE
AF
A